News
Sara Davis Named Theorem Vice President of Global Business Development
Theorem Clinical Research, a full-service contract research organization (CRO) that provides core clinical research and development services, is pleased to announce the appointment of Sara Davis as vice president of global business development. Davis has more than 15 years of sales and management experience and a proven track record of building industry-leading business development teams. She will be responsible for driving strategic business development growth plans for Theorem in all regions of the world.
“Sara’s depth of experience spans a variety of market segments from short-term tactical deals to large, multiyear, multimillion-dollar strategic partnerships,” said Dr. John Potthoff, Theorem president and CEO. “We are just entering what we see as a long period of growth and Sara is ideal to help us manage the road up.”
Davis began her career as an account executive with PRA International. Holding positions of increasing responsibility, she has successfully sold in both the biotech and pharmaceutical industries. She is a graduate of the University of Wisconsin Oshkosh with a Bachelor of Science degree.
About Theorem Clinical Research
Theorem Clinical Research Inc. is a leading midsized provider of comprehensive clinical research and development services with offices in more than 30 countries and a customer base comprised of some of the world’s leading pharmaceutical, biotech and medical device companies. A leader in medical device and drug-device combination trials in addition to a notable capability in pharmaceuticals and biologics, Theorem has deep expertise in a broad range of therapeutic areas and in all phases of development. Some of the industry’s top scientists and most advanced clinical analytics capabilities help ensure smooth-running, successful trials. For a full-service, right-size global research partner, don’t think twice. THINK THEOREM.